Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JZP-110 driving study in OSA
NCT02806895Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Jul 2016
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solriamfetol in obstructive sleep apnea (OSA), sponsored by Jazz Pharmaceuticals plc. Started Jul 2016; status: completed.
02
Drugs
solriamfetol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT02806895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806895.